Publication Search

Search for publications by

E-selectin up-regulation allows for targeted drug delivery in prostate cancer


We have used the Eos Hu03 GeneChip array, which represents over 92% of the transcribed human genome, to measure gene expression in a panel of normal and diseased human tissues. This analysis revealed that E-selectin mRNA is selectively overexpressed in prostate cancer epithelium, a finding that correlated strongly with E-selectin protein expression as assessed by immunohistochemistry. Antibodies against E-selectin that blocked function failed to impede cancer cell growth, suggesting that overexpression of E-selectin was not essential for cell growth. However, a novel auristatin E-based antibody drug conjugate (ADC), E-selectin antibody valine-citrulline monomethyl-auristatin E, was a potent and selective agent against E-selectin-expressing cancer cell lines in vitro, with the degree of cytotoxicity varying with surface antigen density. Interestingly, sensitivity to the ADC differed among cell lines from different tissues expressing similar amounts of E-selectin and was found to correlate with sensitivity to free auristatin E. Furthermore, E-selectin-expressing tumors grown as xenografts in severe combined immunodeficient mice were responsive to treatment with E-selectin antibody valine-citrulline monomethyl-auristatin E in vivo, with more than 85% inhibition of tumor growth observed in treated mice. These findings demonstrate that an E-selectin-targeting ADC has potential as a prostate cancer therapy and validates a genomics-based paradigm for the identification of cancer-specific antigens suitable for targeted therapy.

Type Journal
ISBN 0008-5472 (Print)
Authors Bhaskar, V.;Law, D. A.;Ibsen, E.;Breinberg, D.;Cass, K. M.;DuBridge, R. B.;Evangelista, F.;Henshall, S. M.;Hevezi, P.;Miller, J. C.;Pong, M.;Powers, R.;Senter, P.;Stockett, D.;Sutherland, R. L.;von Freeden-Jeffry, U.;Willhite, D.;Murray, R.;Afar, D. E.;Ramakrishnan, V. :
Publisher Name CANCER RES
Published Date 2003-01-01 00:00:00
Published Volume 63
Published Issue 19
Published Pages 6387-94
Status Published In-print